Altimmune (ALT) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Altimmune (ALT) over the last 15 years, with Q3 2025 value amounting to $0.08.
- Altimmune's Debt to Equity changed N/A to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.08, marking a year-over-year change of. This contributed to the annual value of $0.02 for FY2022, which is 3474.0% down from last year.
- Per Altimmune's latest filing, its Debt to Equity stood at $0.08 for Q3 2025.
- Altimmune's 5-year Debt to Equity high stood at $0.09 for Q2 2025, and its period low was $0.01 during Q2 2021.
- In the last 4 years, Altimmune's Debt to Equity had a median value of $0.02 in 2023 and averaged $0.03.
- Data for Altimmune's Debt to Equity shows a peak YoY increase of 36799.66% (in 2021) and a maximum YoY decrease of 8368.01% (in 2021) over the last 5 years.
- Quarter analysis of 4 years shows Altimmune's Debt to Equity stood at $0.04 in 2021, then crashed by 34.74% to $0.02 in 2022, then rose by 15.78% to $0.03 in 2023, then soared by 171.9% to $0.08 in 2025.
- Its Debt to Equity was $0.08 in Q3 2025, compared to $0.09 in Q2 2025 and $0.03 in Q3 2023.